Work

Measurement of functional mobility in multiple sclerosis: A crosswalk between the patient-determined disease steps and the Neuro-QoL Lower Extremity Function—Short Form

Year: 2026

Type: article

Abstract: Background: The Patient-Determined Disease Steps (PDDS) and Neuro-QoL Lower Extremity Function-Short Form (Neuro-QoL LEF-SF) are patient-reported outcome measures used to monitor mobility symptoms in multiple sclerosis (MS). Objective: To develop and validate a crosswalk between the PDDS and Neuro-QoL LEF-SF. Methods: Using equipercentile equating, we created a crosswalk from a training sample of 619 MS patients (mean PDDS = 2.4 ± 2.3; mean Neuro-QoL LEF-SF = 33.0 ± 8.3). Validation was performed in a separate sample of 147 MS patients (mean PDDS = 0.6 ± 1.2; mean Neuro-QoL LEF-SF = 38.9 ± 2.8). Agreement between original and converted scores was evaluated using paired t-tests and concordance correlation coefficients. Results: = -0.76) samples. No significant differences in change scores were observed. Concordance coefficients of original and converted scores supported good to very good agreement. Conclusion: We developed a crosswalk for the conversion of scores between the PDDS and the Neuro-QoL LEF-SF for patients with MS. Evidence for the preliminary validity of this crosswalk was demonstrated with both the initial training sample and a separate validity sample. This crosswalk facilitates score comparisons and data harmonization across studies and clinical registries using either measure.

Source: Multiple Sclerosis Journal - Experimental Translational and Clinical

DOI: 10.1177/20552173261427107

Authors: Alexa S Gonzalez, Joshua M Garcia, Eric Engebretson, Luis D Medina

Institutions: University of Houston, University of Colorado Anschutz, Baylor College of Medicine

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,650